|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-12-3
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The purpose of this study was to evaluate the optimal renoprotective effect of ultrahigh doses of lisinopril, as reflected by short-term changes in urinary albumin excretion rate (UAER), in type 1 diabetic patients with diabetic nephropathy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1432-0428
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
46-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18974967-Adult,
pubmed-meshheading:18974967-Albuminuria,
pubmed-meshheading:18974967-Antihypertensive Agents,
pubmed-meshheading:18974967-Cross-Over Studies,
pubmed-meshheading:18974967-Diabetes Mellitus, Type 1,
pubmed-meshheading:18974967-Diabetic Angiopathies,
pubmed-meshheading:18974967-Diabetic Nephropathies,
pubmed-meshheading:18974967-Dose-Response Relationship, Drug,
pubmed-meshheading:18974967-Double-Blind Method,
pubmed-meshheading:18974967-Female,
pubmed-meshheading:18974967-Glomerular Filtration Rate,
pubmed-meshheading:18974967-Humans,
pubmed-meshheading:18974967-Lisinopril,
pubmed-meshheading:18974967-Male,
pubmed-meshheading:18974967-Middle Aged,
pubmed-meshheading:18974967-Protective Agents
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
|
|
pubmed:affiliation |
Steno Diabetes Center, Gentofte, Denmark. kjos@steno.dk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
